Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Verified Market Research | PRODUCT CODE: 1628347

Cover Image

PUBLISHER: Verified Market Research | PRODUCT CODE: 1628347

Global Creatinine Measurement Market Size By Type, By Sample Type, By Product, By Geographic Scope And Forecast

PUBLISHED:
PAGES: 202 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3950
PDF & Excel (5 User License)
USD 4850
PDF & Excel (Enterprise User License)
USD 7550

Add to Cart

Creatinine Measurement Market Size And Forecast

Creatinine Measurement Market size was valued at USD 360.3 Million in 2018 and is projected to reach USD 672.18 Million by 2026, growing at a CAGR of 8.06% from 2019 to 2026.

The high prevalence of renal disorders in developed as well as developing countries is a major factor fueling the Creatinine Measurement Market growth globally. Furthermore, growing awareness and adoption of preventive healthcare approaches, the increasing number of technological advancements, and the introduction of monitoring technologies propel the growth of the market. The Global Creatinine Measurement Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Creatinine Measurement Market Definition

Creatinine is a synthesized blood chemical waste product which is generated from the breakdown of the muscle tissues and passes through the kidneys to be filtered and eliminated in urine. In other words, it is an endogenous by-product of muscle metabolism. The creatinine test is a sensitive test used to measure the glomerular filtration rate of the kidney. In the blood, levels of creatinine reflect the amount of muscle and the amount of kidney function of a person. The factors affecting the level of creatinine in the blood are activity level, body size, and medications.

Global Creatinine Measurement Market Overview

The high prevalence of renal disorders in developed as well as developing countries is a major factor fueling the Creatinine Measurement Market growth globally. According to the American Kidney Fund estimation, approximately 31 million U.S. population suffers from Chronic Kidney Disease. Moreover, the initiatives taken by various government and non-governmental organizations to promote renal health is boosting market growth. Furthermore, growing awareness and adoption of preventive healthcare approaches, the rising number of drug development initiatives, the increasing number of technological advancements, and the introduction of monitoring technologies propel the growth of the market.

There are certain restraints and challenges faced which will hinder the market growth. The lack of predictive value obtained by creatinine measurement techniques and shifting the focus of professionals towards novel renal dysfunction biomarkers are the factors that might restrict the growth of the Creatinine Measurement Market. Furthermore, stringent regulatory policies are anticipated to hamper the growth of the market.

Global Creatinine Measurement Market Segmentation Analysis

The Global Creatinine Measurement Market is segmented on the basis of Type, Sample Type, Product, And Geography.

Creatinine Measurement Market, By Type

  • Jaffe's Kinetic Method
  • Enzymatic Method

Based on Type, The market is bifurcated into Jaffe's Kinetic Method, and Enzymatic Method. Jaffe's kinetic method segment is projected to account for the largest share of the Creatinine Measurement Market, owing to factors such as it is the oldest and most conventional method for creatinine measurement in clinical samples. Furthermore, the extensive availability and cost-effectiveness of reagents and kits used in Jaffe's kinetic method is another crucial factor accountable for the large share of this segment.

Creatinine Measurement Market, By Sample Type

  • Blood/Serum
  • Urine

Based on Sample Type, The market is bifurcated into Blood/Serum, and Urine. The blood sample segment accounted for the largest share of the Creatinine Measurement Market owing to the improved accuracy and low risk of contamination. This segment is also projected to witness the highest growth during the forecast period, as it is the utmost preferred sample type for precise measurement of creatinine levels.

Creatinine Measurement Market, By Product

  • Reagents
  • Kits

Based on Product, The market is bifurcated into Reagents, and Kits. The reagent segment accounted for the largest market share in the global Creatinine Measurement Market by-product due to the easy accessibility and low cost of reagents as compared to the commercially available kits, the market for reagents is projected to grow during the forecast period.

Creatinine Measurement Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Regional Analysis, The Global Creatinine Measurement Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share in the market will be dominated by North America. This can be attributed to factors such as the increasing prevalence of kidney disorders in the region, availability of well-developed healthcare infrastructure together with growing healthcare expenditure will foster regional business growth.

Key Players

The "Global Creatinine Measurement Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Thermo Fisher Scientific, Arbor Assays, BioAssay Systems, Abcam plc, Randox Laboratories Ltd., MedTest Holdings, Inc., Sentinel CH. SpA, Abbexa Ltd., DiaSys Diagnostic Systems GmbH, and General Atomics, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

  • To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our Sales Team at Verified Market Research.
  • Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter's five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
  • Customization of the Report
  • In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.
Product Code: 27405

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CREATININE MEASUREMENT MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CREATININE MEASUREMENT MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CREATININE MEASUREMENT MARKET, BY TYPE

  • 5.1 Overview
  • 5.2 Jaffe's Kinetic Method
  • 5.3 Enzymatic Method

6 GLOBAL CREATININE MEASUREMENT MARKET, BY SAMPLE TYPE

  • 6.1 Overview
  • 6.2 Blood/Serum
  • 6.3 Urine

7 GLOBAL CREATININE MEASUREMENT MARKET, BY PRODUCT

  • 7.1 Overview
  • 7.2 Reagents
  • 7.3 Kits

8 GLOBAL CREATININE MEASUREMENT MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East And Africa

9 GLOBAL CREATININE MEASUREMENT MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Thermo Fisher Scientific
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Arbor Assays
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 BioAssay Systems
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Abcam plc
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Randox Laboratories Ltd.
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 MedTest Holdings, Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Sentinel CH. SpA
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Abbexa Ltd.
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 DiaSys Diagnostic Systems GmbH
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 General Atomics, Inc.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!